BR112012021231A2 - method for enhancing plant yield, plant, construct, use of a construct, method for producing a transgenic plant, collectable parts of a plant, products derived from a plant, use of a nucleic acid and method for producing a product - Google Patents

method for enhancing plant yield, plant, construct, use of a construct, method for producing a transgenic plant, collectable parts of a plant, products derived from a plant, use of a nucleic acid and method for producing a product

Info

Publication number
BR112012021231A2
BR112012021231A2 BR112012021231A BR112012021231A BR112012021231A2 BR 112012021231 A2 BR112012021231 A2 BR 112012021231A2 BR 112012021231 A BR112012021231 A BR 112012021231A BR 112012021231 A BR112012021231 A BR 112012021231A BR 112012021231 A2 BR112012021231 A2 BR 112012021231A2
Authority
BR
Brazil
Prior art keywords
plant
construct
producing
nucleic acid
product
Prior art date
Application number
BR112012021231A
Other languages
Portuguese (pt)
Inventor
Christophe Reuzeau
Jenny Russiinova
Original Assignee
Basf Plant Science Co Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Plant Science Co Gmbh filed Critical Basf Plant Science Co Gmbh
Priority claimed from PCT/EP2011/052223 external-priority patent/WO2011104143A1/en
Publication of BR112012021231A2 publication Critical patent/BR112012021231A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
BR112012021231A 2010-02-26 2011-02-15 method for enhancing plant yield, plant, construct, use of a construct, method for producing a transgenic plant, collectable parts of a plant, products derived from a plant, use of a nucleic acid and method for producing a product BR112012021231A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30831610P 2010-02-26 2010-02-26
EP10154814 2010-02-26
PCT/EP2011/052223 WO2011104143A1 (en) 2010-02-26 2011-02-15 Plants having enhanced yield-related traits and a method for making the same

Publications (1)

Publication Number Publication Date
BR112012021231A2 true BR112012021231A2 (en) 2015-09-08

Family

ID=42308270

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012021231A BR112012021231A2 (en) 2010-02-26 2011-02-15 method for enhancing plant yield, plant, construct, use of a construct, method for producing a transgenic plant, collectable parts of a plant, products derived from a plant, use of a nucleic acid and method for producing a product

Country Status (2)

Country Link
BR (1) BR112012021231A2 (en)
WO (1) WO2011104379A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS62701B1 (en) 2011-12-29 2022-01-31 Rhythm Pharmaceuticals Inc Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers
US10960046B2 (en) 2015-09-30 2021-03-30 Rhythm Pharmaceuticals, Inc. Method of treating melanocortin-4 receptor pathway-associated disorders
US20210169969A1 (en) 2018-04-06 2021-06-10 Leonardus H.T. Van Der Ploeg Compositions for treating kidney disease
US20210221867A1 (en) 2018-05-15 2021-07-22 Novo Nordisk A/S Compounds Capable of Binding to Melanocortin 4 Receptor

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731408A (en) 1995-04-10 1998-03-24 Arizona Board Of Regents On Behalf Of The University Of Arizona Peptides having potent antagonist and agonist bioactivities at melanocortin receptors
DE69626660T2 (en) 1995-09-08 2003-08-21 Novo Nordisk As 2-alkylpyrrolidines
CZ220498A3 (en) 1996-01-17 1998-11-11 Novo Nordisk A/S Derivatives of 1,2,4-thiadiazine and 1,4-thiazine, process of their preparation and use
EP0923580A1 (en) 1996-07-26 1999-06-23 Dr. Reddy's Research Foundation Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof
DE69737479T4 (en) 1996-08-30 2010-05-06 Novo Nordisk A/S GLP-1 DERIVATIVES
AU5348098A (en) 1996-12-17 1998-07-15 Quadrant Holdings Cambridge Limited Melanocortins
RU2200161C2 (en) 1996-12-31 2003-03-10 Др. Редди'З Рисерч Фаундейшн Novel derivatives of azolidinedione, method of their synthesis (variants), pharmaceutical compositions based on thereof, method of prophylaxis or treatment, method of glucose level decrease and intermediate compound
DE69727837T2 (en) 1997-05-02 2004-12-30 Dr. Reddy's Research Foundation, Hyderabad NEW ANTIDIABETIC COMPOUNDS WITH HYPOLIPIDIMIC AND ANTI-HYPERTENSIVE PROPERTIES, METHOD FOR THEIR PRODUCTION AND THEIR MEDICINAL PRODUCTS
BR9810378A (en) 1997-07-01 2000-08-29 Novo Nordisk As Compound, use of the same, pharmaceutical composition, and, processes of treating type i or type ii diabetes, of treating hyperglycemia, and of decreasing blood glucose in a mammal
US6613942B1 (en) 1997-07-01 2003-09-02 Novo Nordisk A/S Glucagon antagonists/inverse agonists
KR20010021936A (en) 1997-07-16 2001-03-15 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 Fused 1,2,4-thiadiazine derivatives, their preparation and use
US6440961B1 (en) 1997-10-27 2002-08-27 Dr. Reddy's Research Foundation Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
WO1999019313A1 (en) 1997-10-27 1999-04-22 Dr. Reddy's Research Foundation Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
AU6966498A (en) 1997-12-02 1998-10-30 Dr. Reddy's Research Foundation Thiazolidinedione and oxazolidinedione derivatives having antidiabetic, hypol ipidaemic and antihypertensive properties
JP2002527507A (en) 1998-10-21 2002-08-27 ノボ ノルディスク アクティーゼルスカブ New compounds, their preparation and use
WO2000023415A1 (en) 1998-10-21 2000-04-27 Novo Nordisk A/S New compounds, their preparation and use
WO2000023417A1 (en) 1998-10-21 2000-04-27 Novo Nordisk A/S New compounds, their preparation and use
AU6325799A (en) 1998-10-21 2000-05-08 Dr. Reddy's Research Foundation New compounds, their preparation and use
AU6325599A (en) 1998-10-21 2000-05-08 Dr. Reddy's Research Foundation New compounds, their preparation and use
JP2002527502A (en) 1998-10-21 2002-08-27 ノボ ノルディスク アクティーゼルスカブ New compounds, their preparation and use
HUP0104646A3 (en) 1998-12-18 2004-05-28 Novo Nordisk As Fused 1,2,4-thiadiazine derivatives, their preparation and use
WO2000041121A1 (en) 1999-01-07 2000-07-13 Ccrewards.Com Method and arrangement for issuance and management of digital coupons and sales offers
WO2000042026A1 (en) 1999-01-15 2000-07-20 Novo Nordisk A/S Non-peptide glp-1 agonists
WO2000042023A1 (en) 1999-01-18 2000-07-20 Novo Nordisk A/S Substituted imidazoles, their preparation and use
AU2953699A (en) 1999-04-16 2000-11-02 Dr. Reddy's Research Foundation Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
WO2000063189A1 (en) 1999-04-16 2000-10-26 Novo Nordisk A/S Crystalline r- guanidines, arginine or (l) -arginine (2s) -2- ethoxy -3-{4- [2-(10h -phenoxazin -10-yl)ethoxy]phenyl}propanoate
BR0010683A (en) 1999-04-16 2003-07-01 Reddy Research Foundation Polymorphic forms of an antidiabetic agent: process for its preparation and pharmaceutical compositions containing the same
WO2000063208A1 (en) 1999-04-16 2000-10-26 Novo Nordisk A/S Substituted imidazoles, their preparation and use
EP1171431A1 (en) 1999-04-20 2002-01-16 Novo Nordisk A/S Compounds, their preparation and use
EP1171414A1 (en) 1999-04-20 2002-01-16 Novo Nordisk A/S Compounds, their preparation and use
AU3958100A (en) 1999-04-20 2000-11-02 Novo Nordisk A/S New compounds, their preparation and use
AU3958200A (en) 1999-04-20 2000-11-02 Novo Nordisk A/S New compounds, their preparation and use
AU3957600A (en) 1999-04-26 2000-11-10 Boehringer Ingelheim International Gmbh Piperidyl-imidazole derivatives, their preparations and therapeutic uses
ATE297907T1 (en) 2000-07-20 2005-07-15 Hoffmann La Roche ALPHA-ACYL AND ALPHA-HETEROATOM SUBSTITUTED BENZENACETAMIDE USABLE AS GLUCOCINASE ACTIVATORS
ES2278016T3 (en) 2001-04-09 2007-08-01 Novartis Vaccines And Diagnostics, Inc. GUANIDINE COMPOUNDS AS AGONISTS OF THE RECEIVER OF MELANOCORTINA 4 (MC4-R).
CA2453515A1 (en) 2001-07-11 2003-01-23 Palatin Technologies, Inc. Linear and cyclic melanocortin receptor-specific peptides
WO2003007949A1 (en) 2001-07-18 2003-01-30 Merck & Co., Inc. Bridged piperidine derivatives as melanocortin receptor agonists
US7115607B2 (en) 2001-07-25 2006-10-03 Amgen Inc. Substituted piperazinyl amides and methods of use
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
KR20080031414A (en) 2005-07-18 2008-04-08 노보 노르디스크 에이/에스 Novel peptides for use in the treatment of obesity
EP2104684A1 (en) 2007-01-18 2009-09-30 Novo Nordisk A/S Peptides for use in the treatment of obesity
WO2008087186A2 (en) 2007-01-18 2008-07-24 Novo Nordisk A/S Peptides for use in the treatment of obesity
EP2106407A2 (en) * 2007-01-18 2009-10-07 Novo Nordisk A/S Novel peptides for use in the treatment of obesity

Also Published As

Publication number Publication date
WO2011104379A1 (en) 2011-09-01

Similar Documents

Publication Publication Date Title
BR112014009488A2 (en) method for improving production-related characteristics, construct plants, use of a construct, method for production, transgenic plant, collectable parts and products derived from a plant, use of a nucleic acid and method for manufacturing a product
BR112014011532A2 (en) method for producing a transgenic plant, part of the same plant or plant cell, construct, use of a construct, collectable parts of a plant and products derived from a plant
BR112012000421A2 (en) compositions and methods for enhancing the production of a biological product.
BR112014006912A2 (en) method for enhancing corn plant growth
BR112013028410A2 (en) process for the preparation of isomaltulose from plant sap
BR112013013042A2 (en) process for preparing a pharmaceutical formulation containing ppi
BR112013033176A2 (en) method for producing a targeted modification on a male fertility gene, plant, isolated nucleic acid molecule, expression construct
BR112012006415A2 (en) method for preparing plant derived vlps
BR112014005400A2 (en) method to increase the growth of a plant and composition
BR112014007642A2 (en) methods for producing a seed set and for providing a set of parent plants for producing a plant
BR112014001387A2 (en) method for producing a transgenic plant
BR112012032494A2 (en) product, use and method of production of a product
BR112013001424A2 (en) method for accenting traits related to plant yield, plant, construct, use of a construct, method for producing a transgenic plant, transgenic plant, harvestable parts of a plant, plant derived products, use of a nucleic acid and method to improve plant yield traits
FI20095500A0 (en) Product and process for its preparation
BR112013029288A2 (en) method for enhancing one or more traits related to plant production and for the production of a transgenic plant, plant expression construct, transgenic plant, collectable parts of a plant, product and use of a nucleic acid and a construct
BR112014000151A2 (en) method to produce a confectionery product
DK2916943T3 (en) PRODUCTION PLANT FOR A CHEMICAL OR PHARMACEUTICAL PRODUCT
BR112013000992A2 (en) methods for enhancing yield traits in plants, constructs, uses of a construct, plants, plant parts, transformed plant cells, methods for producing a transgenic plant, transgenic plants, harvestable parts and products derived from a plant, uses of a nucleic acid, isolated nucleic acid molecules, isolated polypeptides and use of rna helicase dead-box nucleic acids
BR112012023505A2 (en) Method for enhancing plant performance traits in relation to control plants, plant or part thereof, use of a construct, method for producing an increased yield transgenic plant, transgenic plant, harvestable parts of a plant, products derivatives of a plant and use of a nucleic acid
BR112013025022A2 (en) method to promote plant growth
BR112012021231A2 (en) method for enhancing plant yield, plant, construct, use of a construct, method for producing a transgenic plant, collectable parts of a plant, products derived from a plant, use of a nucleic acid and method for producing a product
BR112014012501A2 (en) method for producing a transgenic plant, construction, harvestable parts of a plant, products derived from a plant, use of a nucleic acid, method for making a product and recombinant crossomic DNA
BR112012033668A2 (en) transgenic plant and seed, method for producing a transgenic plant, product and / or by-product obtained from the transgenic seed, isolated polynucleotide and plant or seed comprising a recombinant DNA construct
PL2572137T3 (en) Plant for working products
BRPI1100056A2 (en) method to disinfect a bottle

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]